ARCHIVES

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

News Council Says Post Series “Flawed By Sensationalism”

June 11, 1982

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

Raising NIH Appropriations Is High Priority, House Subcommittee Chairman Says

March 7, 1997

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997